Almirall MCP
REMOTE · MCP.ALMIRALL.COM
Official Almirall company, product and brand info: Almax, Hidroxil, Calmatel, Cicopoli and more.
Available components
Last scanned (21 hours ago)
Scores higher than 91% of remote servers
Reachable. Last reached 21 Nov 2026.
Category Health and Science
How this component scores in each security and reliability category. Every signal is checked automatically against the live server, and we only credit what we can confirm. How we score → Why this is hard to score →
Endpoint Security74
- The endpoint's TLS certificate is valid, in date, and uses a strong key. View diagnostics → Pass
- No authorisation is required to call this server. Nothing on it is marked destructive, but we can't show that an anonymous caller can only read: full credit needs the server to list at least one tool and every tool to be verifiably read-only. We use a best-effort check of tool names and descriptions to tell read-only tools from tools that change things, so some genuinely read-only tools may not get full credit. Names that start with a read verb (get, list, read, search and similar) and accurate readOnlyHint annotations help. Meet that to earn full credit, or require authorisation. See how to fix → View diagnostics → Partial
- HTTPS is enforced; there's no plaintext access path. View diagnostics → Pass
- HSTS check failed: the Strict-Transport-Security header is absent. See how to fix → View diagnostics → Fail
- DNSSEC check failed: this domain isn't protected by DNSSEC. See how to fix → View diagnostics → Fail
Transport & Reachability100
- Verified streamable-http transport via a live MCP handshake. View diagnostics → Pass
Schema Quality & AI Usability85
- 100% of prompts and resources have a non-trivial description (not blank, and not just the item's name).Pass
- AI-judged instruction clarity (good).Pass
- Tool/resource definitions use about 30669 tokens (~59/item across 514 items; 14 tools + 500 resources), lean.Pass
- Usage-examples check failed: none of the tools include examples. See how to fix → Fail
Stability & Change Management100
- No destabilizing schema changes in the last 30 days.Pass
Tool Coverage99
- 100% of tools have a non-trivial description (not blank, and not just the tool's name).Pass
- 97% of tool parameters carry a description.Partial
Tool Safety100
- No prompt-injection markers were found in the server instructions, tool names or descriptions we captured.Pass
- We read all 14 captured tool definition(s), and no name or description among them implies an irreversible operation.Pass
- An AI judge read all 15 captured unit(s) of tool text and found none that tries to manipulate the model reading it.Pass
Capabilities100
- Implements a current MCP spec version (2026-07-28).Pass
Checks we ran (13)
- TLS certificate
- Authorization
- HTTPS
- HSTS header
- DNSSEC
- Transport
- Schema quality
- Stability
- Tool coverage
- Injection markers
- Destructive annotations
- Judged manipulation
- MCP protocol
Does not apply to this hosted endpoint (2)
- Supply Chain SecurityScored on package channels only. This is a hosted endpoint, so there is nothing to install or inspect.
- Provenance & TransparencyScored on package channels only. This is a hosted endpoint, so there is nothing to install or inspect.
The score does not measure everything. What the score does not measure →
Every change we have recorded for this component, newest first. Security-relevant changes are always shown. ▲ marks a change for the better, ▼ a change for the worse; unmarked changes are neutral.
- 21 Nov 26 0
- Resource ““Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall” now points somewhere else: almirall://content/almirall-com/2dcf88f319778867765310d2b5775e1e49f101d5d87293a31ae6264f7a47298b → almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf security
- 20 Nov 26 0
- Resource ““Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall” now points somewhere else: almirall://content/almirall-com/2dcf88f319778867765310d2b5775e1e49f101d5d87293a31ae6264f7a47298b → almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf security
- Tool “compare_content” rewrote its description, which is the text the model reads security
- Tool “get_page” rewrote its description, which is the text the model reads security
- Tool “list_pages” rewrote its description, which is the text the model reads security
- Tool “search_content” rewrote its description, which is the text the model reads security
- Tool “search_tools” rewrote its description, which is the text the model reads security
- “compare_content” reworded the description of “items” cosmetic
- “compare_content” reworded the description of “query” cosmetic
- “get_page” reworded the description of “documentId” cosmetic
- “get_page” reworded the description of “url” cosmetic
- “search_tools” reworded the description of “query” cosmetic
- 19 Nov 26 0
- Resource ““Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall” now points somewhere else: almirall://content/almirall-com/2dcf88f319778867765310d2b5775e1e49f101d5d87293a31ae6264f7a47298b → almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf security
- Tool “get_chunk” rewrote its description, which is the text the model reads security
- Resource “5975429d 8cc3 28c6 492c 16c50c97da78” was removed ▼ functional
- Resource “597bc105 6ecc 7fd3 1868 e11131c984e0” was removed ▼ functional
- Resource “62ba50df 5207 5532 c632 06da481e6faa” was removed ▼ functional
- Resource “64f26ecc b248 da38 e3d0 76fb82003cd1” was removed ▼ functional
- Resource “651 EN NP Convenio F Galatea English165152” was removed ▼ functional
- Resource “655 EN 07 OHSAS certificate (ingles)165171” was removed ▼ functional
- Resource “656 EN Almirall premio mejor compania (ingles)165185” was removed ▼ functional
- Resource “661 EN PR First day of listing165213” was removed ▼ functional
- Resource “662 EN Appointment Jordi Molina165232” was removed ▼ functional
- Resource “663 EN PR prospectus results 2006165251” was removed ▼ functional
- Resource “664 EN NP Tramo empleados (ingles)165270” was removed ▼ functional
- Resource “665 EN Short text for global (ingles)165289” was removed ▼ functional
- Resource “666 EN Nota de prensa (ingles)165308” was removed ▼ functional
- Resource “667 EN PR Positive first day of trading165327” was removed ▼ functional
- Resource “668 EN Press release Hermal acquisition165346” was removed ▼ functional
- Resource “670 EN PR Global Medical Director Almirall RD (ingles)165374” was removed ▼ functional
- Resource “671 EN Resultados 1er simestre 2007 (ingles)165388” was removed ▼ functional
- Resource “673 EN Press release (English)165407” was removed ▼ functional
- Resource “674 EN Press Release165426” was removed ▼ functional
- Resource “675 EN Press release165445” was removed ▼ functional
- Resource “676 EN PR Appointment Klaus Melchers165464” was removed ▼ functional
- Resource “678 EN Nota de prensa (ingles)165483” was removed ▼ functional
- Resource “679 EN PR Appointment165502” was removed ▼ functional
- Resource “67e1f2b5 910a 3de8 edce 8e36e1b4cc81” was removed ▼ functional
- Resource “680 EN PR Appointments165521” was removed ▼ functional
- Resource “681 EN Nota de prensa ingles165540” was removed ▼ functional
- Resource “682 EN Press release165559” was removed ▼ functional
- Resource “683 EN Press release165578” was removed ▼ functional
- Resource “684 EN Press release165597” was removed ▼ functional
- Resource “6856f0c6 7c8c b291 cb81 c5ff1f4dcffc” was removed ▼ functional
- Resource “689 EN PR Appointment (English)165616” was removed ▼ functional
- Resource “690 EN Press Release165635” was removed ▼ functional
- Resource “691 EN Press Release165654” was removed ▼ functional
- Resource “692 EN PR165673” was removed ▼ functional
- Resource “693 EN PR165692” was removed ▼ functional
- Resource “694 EN PR165711” was removed ▼ functional
- Resource “695 EN PR165730” was removed ▼ functional
- Resource “696 EN PR165749” was removed ▼ functional
- Resource “697 EN PR165768” was removed ▼ functional
- Resource “698 EN PR165787” was removed ▼ functional
- Resource “699 EN NP CL25 eng web165806” was removed ▼ functional
- Resource “6a8d2a45 2d32 1149 c9d7 a2e6c258d068” was removed ▼ functional
- Resource “6bf0b8f4 7bca e704 bc8e a109ada4d0ff” was removed ▼ functional
- Resource “7 HSE Policy” was removed ▼ functional
- Resource “7000db46 7424 d891 4b5b 65abd63694ad” was removed ▼ functional
- Resource “75d4adb6 b883 52e1 5736 f068ee091a81” was removed ▼ functional
- Resource “7bc39384 c206 5c62 b1ca 6fbe0f2cefdf” was removed ▼ functional
- Resource “7e0d458d 09cb 7170 4292 38a9d6595376” was removed ▼ functional
- Resource “8 CDP Climate and Water Response” was removed ▼ functional
- Resource “8 de cada 10 españoles no sabe qué es la EPOC | Almirall” was removed ▼ functional
- Resource “82d759ca a64a 2e2d b728 b52a47ba5526” was removed ▼ functional
- Resource “83571e7a 2358 d9bf f852 314e3a939258” was removed ▼ functional
- Resource “85% of people unaware of actinic keratosis, the most common pre-cancerous skin condition | Almirall” was removed ▼ functional
- Resource “8613f0e1 2b03 ed5d a771 bab806ba134b” was removed ▼ functional
- Resource “878d6387 f0ee b020 d806 176c2384b14c” was removed ▼ functional
- Resource “87fc3c00 aea4 f352 b133 6a542a183494” was removed ▼ functional
- Resource “8a4881a3 6c5d 55f1 2d53 3dd5798545aa” was removed ▼ functional
- Resource “8a73cd38 4c02 e188 60ec 7b24635e36f9” was removed ▼ functional
- Resource “8b6e199c e2a9 8a11 be38 c01b2f4ca99e” was removed ▼ functional
- Resource “8d5f7d4a 0d26 2b02 6891 94e966516431” was removed ▼ functional
- Resource “900 EN PR165825” was removed ▼ functional
- Resource “901 EN PR165844” was removed ▼ functional
- Resource “902 EN PR165863” was removed ▼ functional
- Resource “903 EN PR165882” was removed ▼ functional
- Resource “904 EN Press Release ACCLAIM results165901” was removed ▼ functional
- Resource “9172d05a a4b2 dfb2 9726 e52558d8aaaf” was removed ▼ functional
- Resource “9211f466 3d41 d73a e58a 5f6c4cc6a35d” was removed ▼ functional
- Resource “92e9fe63 be02 1ef4 eb62 bebd97524cc5” was removed ▼ functional
- Resource “94462c13 f4fc d00e 4d96 54cec21e378e” was removed ▼ functional
- Resource “95bdce8e ab10 1591 e3ce 906b75f47a9f” was removed ▼ functional
- Resource “97191204 6c73 475b ade9 d07083298d7b” was removed ▼ functional
- Resource “972430fb 390f 5456 e7bf 1576077b4f7b” was removed ▼ functional
- Resource “9c03304f 0cd3 f041 7bbd 53533b3aa2b4” was removed ▼ functional
- Resource “9d129a34 ecd7 5fec 5451 0164509a315e” was removed ▼ functional
- Resource “9e92beb2 fd9f 4adb 497e 94ca2fbaad1c” was removed ▼ functional
- Resource “A comparative study classifies Almogran as one of the best choices for the treatment of migraines. | Almirall” was removed ▼ functional
- Resource “A letter from our CEO” was removed ▼ functional
- Resource “A multidisciplinary approach to improve treatment and reduce patient cardiovascular risk | Almirall” was removed ▼ functional
- Resource “A survey reveals that two in five European persons with Multiple Sclerosis (MS) under 35 are unable to work or study due to their illness | Almirall” was removed ▼ functional
- Resource “AAD 2026: Almirall presents new clinical and real‑world evidence across atopic dermatitis, psoriasis, actinic keratosis and acne | Almirall” was removed ▼ functional
- Resource “Abediterol, Almirall's OD LABA shows superiority vs indacaterol in Phase IIa | Almirall” was removed ▼ functional
- Resource “About Almirall ENG 1” was removed ▼ functional
- Resource “About Skin | Almirall” was removed ▼ functional
- Resource “About Us | Almirall” was removed ▼ functional
- Resource “About acne | Almirall” was removed ▼ functional
- Resource “About actinic keratosis | Almirall” was removed ▼ functional
- Resource “About atopic dermatitis | Almirall” was removed ▼ functional
- Resource “About psoriasis | Almirall” was removed ▼ functional
- Resource “About us | Almirall” was removed ▼ functional
- Resource “Accesibility Policy | Almirall” was removed ▼ functional
- Resource “Accessibility Policy | Almirall” was removed ▼ functional
- Resource “Accessibility Policy – Nordics” was removed ▼ functional
- Resource “According to the survey on the El Club de la Farmacia website, a portal to which over 30,000 pharmacists subscribe, three out of every five pharmacists are in favour of dispensing cannabis in their pharmacies | Almirall” was removed ▼ functional
- Resource “Aclidinium and formoterol fixed dose combination for COPD submitted for registration in Europe | Almirall” was removed ▼ functional
- Resource “Aclidinium bromide demonstrates rapid and long-acting bronchodilatory effect in COPD | Almirall” was removed ▼ functional
- Resource “Aclidinium bromide submitted for registration in Europe | Almirall” was removed ▼ functional
- Resource “Aclidinium clinical data published in the European Respiratory Journal confirms efficacy and safety of this new treatment for COPD patients | Almirall” was removed ▼ functional
- Resource “Aclidinium, chosen as one of the best Spanish therapeutic innovations with an international reach | Almirall” was removed ▼ functional
- Resource “a3dcfded 6cbb c8d6 8a49 994cd6793149” was removed ▼ functional
- Resource “a44526ce c500 5d85 8baa d54acf4c4794” was removed ▼ functional
- Resource “a64404f6 3462 cd89 61cf c3bbbb7c61e0” was removed ▼ functional
- Schema quality: 36773 → 30483 ▲ functional
- New resource “20260609 Almirall OIR Admision a negociacion ENG” functional
- “get_chunk” reworded the description of “chunkIndex” cosmetic
- “get_chunk” reworded the description of “documentId” cosmetic
- “get_chunk” reworded the description of “uid” cosmetic
- 18 Nov 26 0
- Resource ““Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall” now points somewhere else: almirall://content/almirall-com/2dcf88f319778867765310d2b5775e1e49f101d5d87293a31ae6264f7a47298b → almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf security
- 17 Nov 26 0
- Resource ““Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall” now points somewhere else: almirall://content/almirall-com/2dcf88f319778867765310d2b5775e1e49f101d5d87293a31ae6264f7a47298b → almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf security
- 16 Nov 26 0
We did not load change detail this far back for this component, so this day may have recorded more than is shown.
- Resource “Almirall and the Spanish Society of Pharmacology confer the Pharmacology Award 2008 | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Laboratories Announce Positive Results of Clinical Studies for Aclidinium Bromide, A Novel Long-Acting Anticholinergic for the Treatment for COPD | Almirall” was removed ▼ functional
- Resource “Almirall announces CFO transition plan and appoints Jon U. Garay Alonso as CFO to succeed Mike McClellan in August 2025 | Almirall” was removed ▼ functional
- Resource “Almirall acquires Hermal, the European prescription dermatology business of Reckitt Benckiser for £ 255 million (€ 376 million ) | Almirall” was removed ▼ functional
- Resource “Almirall closes agreement with Allergan and acquires its US medical dermatology portfolio | Almirall” was removed ▼ functional
- Resource “Almirall announces multi-target licensing agreement with Ablexis and collaboration with AlivaMab Discovery Services to accelerate antibody drug discovery and development | Almirall” was removed ▼ functional
- Resource “Almirall and WuXi Biologics sign strategic collaboration agreement for multiple bispecific antibodies targeting dermatology diseases | Almirall” was removed ▼ functional
- Resource “Almirall - Ranke Química reduced its accident rate by 57% in 2007 | Almirall” was removed ▼ functional
- Resource “Acne diagnosis | Almirall” was removed ▼ functional
- Resource “Almirall and the Spanish Pharmacology Society confer the pharmacology award 2007 | Almirall” was removed ▼ functional
- Resource “Almirall begins the transformation | Almirall” was removed ▼ functional
- Resource “Almirall acquires a portfolio of eight products from Shire plc for US$213 million (€151 million ) | Almirall” was removed ▼ functional
- Resource “Almirall agrees strategic transaction with astrazeneca in respiratory disease | Almirall” was removed ▼ functional
- Resource “AI | Almirall” was removed ▼ functional
- Resource “Almirall and Happify Health go live with digital therapeutics support for psoriasis patients | Almirall” was removed ▼ functional
- Resource “Almirall and Lundbeck announce a co-promotion agreement for escitalopram in Italy | Almirall” was removed ▼ functional
- Resource “Aknenormin 20 mg ulotka IB 03 2026 c” was removed ▼ functional
- Resource “Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin disease | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Laboratories announce positive results of a Phase III Study for aclidinium and formoterol combination in COPD | Almirall” was removed ▼ functional
- Resource “Almirall announces the appointment of Eduardo Sanchiz as new CEO as of July 1st 2011 | Almirall” was removed ▼ functional
- Resource “Almirall announces the successful pricing of a €250 MM offering of senior unsecured conditionally convertible bonds due 2021 | Almirall” was removed ▼ functional
- Resource “Almirall announces approval of the reimbursed price for Ilumetri®(tildrakizumab) in France for the treatment of adult patients with severe chronic plaque psoriasis | Almirall” was removed ▼ functional
- Resource “Almirall and Forest announce a development and marketing collaboration agreement on new therapy for COPD | Almirall” was removed ▼ functional
- Resource “Acne treatments | Almirall” was removed ▼ functional
- Resource “Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo | Almirall” was removed ▼ functional
- Resource “Almirall and Kaken Pharmaceutical enter into a license and distribution agreement for European rights to the topical formulation of efinaconazole | Almirall” was removed ▼ functional
- Resource “Almirall achieves Net Sales growth of 6.4%, driven by strong European dermatology performance | Almirall” was removed ▼ functional
- Resource “Actinic Keratosis Types | Almirall” was removed ▼ functional
- Resource “Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology | Almirall” was removed ▼ functional
- Resource “Almirall and Barcelona Supercomputing Center expand their collaboration to accelerate innovation in medical dermatology | Almirall” was removed ▼ functional
- Resource “Acne: What It Is | Almirall” was removed ▼ functional
- Resource “Almirall appoints Mercedes Diz as VP, Corporate Strategy | Almirall” was removed ▼ functional
- Resource “Almirall Advances Skin Science at EADV 2026” was removed ▼ functional
- Resource “Almirall and Ironwood announce positive results from the second Phase III trial of linaclotide in patients with irritable bowel syndrome with constipation | Almirall” was removed ▼ functional
- Resource “Almirall and ASLAN sign a global agreement on a novel treatment for Rheumatoid Arthritis | Almirall” was removed ▼ functional
- Resource “Almirall announces “LumiNE”, a phase III clinical study assessing the efficacy of Lebrikizumab for the treatment of nummular eczema | Almirall” was removed ▼ functional
- Resource “Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases | Almirall” was removed ▼ functional
- Resource “Almirall announces EMA acceptance for filing of paediatric registration of Ebglyss (lebrikizumab) in atopic dermatitis in children 6 months and older | Almirall” was removed ▼ functional
- Resource “Almirall appoints a new Managing Director of its market company in Poland | Almirall” was removed ▼ functional
- Resource “Almirall and HitGen will develop novel oral compounds in atopic dermatitis | Almirall” was removed ▼ functional
- Resource “Almirall calls for partners to develop new immune-dermatology therapies | Almirall” was removed ▼ functional
- Resource “Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in US | Almirall” was removed ▼ functional
- Resource “Almirall and Paratek enter into a License Agreement for Seysara® in China | Almirall” was removed ▼ functional
- Resource “Almirall and Forest announce positive results from the ACCORD COPD I Phase III study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD) | Almirall” was removed ▼ functional
- Resource “Almirall announces the initiation of a phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases | Almirall” was removed ▼ functional
- Resource “Acne triggering factors | Almirall” was removed ▼ functional
- Resource “Almirall | Pharmaceutical Company in Medical Dermatology” was removed ▼ functional
- Resource “Almirall 9M 2018 business results: Strong business momentum | Almirall” was removed ▼ functional
- Resource “Almirall and Evotec enter into a multi-target alliance in Medical Dermatology | Almirall” was removed ▼ functional
- Resource “Almirall announcement | Almirall” was removed ▼ functional
- Resource “Almirall and Forest report preliminary topline results from the ACCORD COPD II Phase III study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD) | Almirall” was removed ▼ functional
- Resource “Almirall announces its intention to list its shares on the Spanish Stock Market | Almirall” was removed ▼ functional
- Resource “Almirall announces EMA acceptance for filing of Marketing Authorization Application (MAA) for lebrikizumab in atopic dermatitis | Almirall” was removed ▼ functional
- Resource “Almirall calls for collaborative innovation to advance new treatments for skin diseases | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Laboratories announce positive results for the second Phase III study for aclidinium and formoterol combination in COPD | Almirall” was removed ▼ functional
- Resource “Almirall announces FDA acceptance for filing of U.S. New Drug Application (NDA) for tirbanibulin in actinic keratosis | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Laboratories announce commercial availability of Tudorza™ Pressair™ in U.S. pharmacies | Almirall” was removed ▼ functional
- Resource “Almirall Announces Initiation of Phase 3 Program Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis | Almirall” was removed ▼ functional
- Resource “Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis | Almirall” was removed ▼ functional
- Resource “Almirall awards dividend payments of 52 million euros to its shareholders | Almirall” was removed ▼ functional
- Resource “Almirall certifies its Occupational Risk Prevention Management System surpassing current legislation in Spain | Almirall” was removed ▼ functional
- Resource “Almirall and Iktos announce research collaboration in Artificial Intelligence for new drug design | Almirall” was removed ▼ functional
- Resource “Almirall apoya el programa de actividades puesto en marcha por la SED y su Fundación para el Día Mundial de la Diabetes | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Laboratories announce FDA has extended the review period for Aclidinium Bromide | Almirall” was removed ▼ functional
- Resource “Almirall and BioFocus announce collaboration to find new hit compounds against key targets | Almirall” was removed ▼ functional
- Resource “Almirall closes $15 million strategic investment in Suneva Medical | Almirall” was removed ▼ functional
- Resource “Actikerall® launched in the UK for the treatment of actinic keratosis, including grade I and II severity | Almirall” was removed ▼ functional
- Resource “Almirall announces collaboration with Sareum for protein structure determination | Almirall” was removed ▼ functional
- Resource “Almirall and Forest Announce Positive FDA Advisory Committee’s Recommendation for Approval of Aclidinium Bromide for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) | Almirall” was removed ▼ functional
- Resource “Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies | Almirall” was removed ▼ functional
- Resource “Almirall achieves Net Sales growth of 7% to €466.1MM, driven by strong growth in European dermatology business | Almirall” was removed ▼ functional
- Resource “Almirall announces the pricing and closing of its €200mm non pre-emptive share capital increase | Almirall” was removed ▼ functional
- Resource “Almirall announces regulatory filing of linaclotide for the treatment of irritable bowel syndrome with constipation in Europe | Almirall” was removed ▼ functional
- Resource “Almirall and Forest to present data from phase III studies of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD) | Almirall” was removed ▼ functional
- Resource “Acne Awareness Month 2026 | Almirall” was removed ▼ functional
- Resource “Almirall announces filing Sativex® regulatory submission | Almirall” was removed ▼ functional
- Resource “Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations | Almirall” was removed ▼ functional
- Resource “Almirall celebrates 10 years in Italy | Almirall” was removed ▼ functional
- 9 Nov 26 +1
We did not load change detail this far back for this component, so this day may have recorded more than is shown.
- 8 Nov 26 −1
We did not load change detail this far back for this component, so this day may have recorded more than is shown.
Diagnostic detail from the automated scan of this channel: what the scanner observed at each step, so you can see exactly where a check passed or failed. It is informational only and never changes the trust score.
Captured 21 Nov 2026 · Probed https://mcp.almirall.com/mcp
TLS valid
Negotiated TLS 1.3 with TLS_AES_256_GCM_SHA384 .
| Subject | Issuer | Valid from | Valid until | Key | Signature | Serial |
|---|---|---|---|---|---|---|
| CN=mcp.almirall.com | CN=Sectigo Public Server Authentication CA DV R36,O=Sectigo Limited,C=GB | 20 Jul 2026 | 3 Feb 2027 | RSA 2048 | SHA256-RSA | 8f52a7dbb20a364785911e1139af3c78 |
| SANs: mcp.almirall.com, www.mcp.almirall.com | ||||||
| CN=Sectigo Public Server Authentication CA DV R36,O=Sectigo Limited,C=GB (CA) | CN=Sectigo Public Server Authentication Root R46,O=Sectigo Limited,C=GB | 22 Mar 2021 | 21 Mar 2036 | RSA 3072 | SHA384-RSA | 397a66cc2756362e0daa87ca6eabe3b1 |
| CN=Sectigo Public Server Authentication Root R46,O=Sectigo Limited,C=GB (CA) | CN=USERTrust RSA Certification Authority,O=The USERTRUST Network,L=Jersey City,ST=New Jersey,C=US | 22 Mar 2021 | 18 Jan 2038 | RSA 4096 | SHA384-RSA | d27fbbc1de359e5216ad6149586099c4 |
| CN=USERTrust RSA Certification Authority,O=The USERTRUST Network,L=Jersey City,ST=New Jersey,C=US (CA) | CN=USERTrust RSA Certification Authority,O=The USERTRUST Network,L=Jersey City,ST=New Jersey,C=US | 1 Feb 2010 | 18 Jan 2038 | RSA 4096 | SHA384-RSA | 1fd6d30fca3ca51a81bbc640e35032d |
Background: What to check on a remote MCP endpoint →
DNSSEC insecure
Validation of mcp.almirall.com. — Not signed
| Zone | DS | Keys | Algorithms | Outcome |
|---|---|---|---|---|
| . | Trust anchor | 20326, 38696 | 8, 8 | Verified |
| com. | DS published | 19718 | 13 | Verified |
| almirall.com. | No DS | Unsigned (proven) parent-signed NSEC/NSEC3 proves an unsigned delegation |
Authentication No authorisation required
The endpoint answered without asking for a token. Anyone who knows the URL can reach it.
| Result | No authorisation required |
|---|---|
| HTTP status | 200 |
Background: How OAuth 2.1 works in the 2026 MCP spec →
Transports 2 probes
| Transport | URL | Outcome | Status | Location |
|---|---|---|---|---|
| streamable-http | https://mcp.almirall.com/mcp | Verified | 200 | |
| http (plaintext) | http://mcp.almirall.com/mcp | HTTPS enforced | 301 | https://mcp.almirall.com |
The tools this component advertises to a client, with an estimated token cost for each. Expand a tool to see its parameters and schema. The per-tool counts are indicative and are not scored directly; the schema's total context footprint is one signal in Schema Quality & AI Usability. A tool's description is untrusted text the model reads on every call, which is what makes this list a security surface and not just an inventory: how tool poisoning works →
compare_content Compare Content ~297
Find grouped evidence for comparing two to five distinct named items, product formats, ranges, topics, or alternatives. Provide their names as strings, for example {"items":["Almax Forte","Almax 500 mg"],"query":"format"}. If names are unknown, discover them with find_product_mentions, search_content or list_pages first. Do not invent names. Each item is searched independently; verify the evidence belongs to the named item and report missing information rather than inferring it. This tool does not resolve exact URLs or documentIds as references.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| items | array | yes | Two to five distinct non-empty names of items or topics, supplied by the user or discovered via find_product_mentions, search_content or list_pages; not URLs or documentIds. |
| query | string | – | Optional aspect to compare, such as ingredients, benefits, usage, format or contraindications. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| topPerItem | integer | – | Maximum number of search results to keep per item. Defaults to 3. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
find_content_assets Find Content Assets ~227
Extract image/media asset URLs from indexed markdown text. Use only when the user asks for product images, media files, visual assets, screenshots, WordPress uploads, or image evidence. For textual questions about extracted page content, use search_content instead. Returns asset URLs plus the real page URL where each asset appeared.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| query | string | – | Optional topic, product, filename, or asset context to search before extracting assets. Defaults to image/product-oriented search. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum number of chunks to inspect for assets. Defaults to at least 10. |
| url | string | – | Optional exact crawled page URL filter. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
find_pages_by_title Find Pages by Title ~184
Resolve the most relevant indexed pages by approximate title match before doing a narrower content search. Use this when the user mentions a brand, product family, or page-like concept but not a domain or URL, and you want to identify the right page first without requiring an exact title match.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter to narrow title matching. A leading www. is removed and the domain is normalized to lowercase. |
| sourceId | string | – | Optional crawler source id to narrow title matching. |
| titleQuery | string | yes | Brand, product, or page title hint to match approximately against indexed page titles. |
| top | integer | – | Maximum number of candidate pages to return. Defaults to 10. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
find_product_mentions Find Product Mentions ~266
Specialized product extraction tool. Use when the user specifically asks what products a crawled brand/site offers, asks for catalog items, variants, product ranges, formulations, product benefits, ingredients by product, or where product claims appear. If the user is asking a general content question rather than enumerating products, use search_content instead. sourceId and domain are optional filters; if you need to discover the right indexed source before narrowing, use list_sources. Returns grouped product mentions with evidence snippets and real page URLs.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| productHint | string | – | Optional known product or brand name to bias extraction and grouping. |
| query | string | yes | Natural-language query describing the product, brand, category, or benefit to detect. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum number of search results to inspect for product mentions. Defaults to at least 8. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
get_almax_dosage_calculator Check Almax Label Dosage Limits ~177
Calculate daily almagate grams for a standard dose of a supported Almax presentation and check the leaflet's age, 8 g/day and 14-day limits. daily_doses_intended means administrations per day, not tablets or sachets. This checks label limits only; it cannot establish individual clinical safety. treatment_days is needed to check duration.
| Name | Type | Req | Description |
|---|---|---|---|
| daily_doses_intended | integer | yes | Number of standard administrations per day; the standard dose size is determined by product_variant. |
| patient_age | integer | yes | – |
| product_variant | string | yes | Almax presentation. forte_comprimidos uses the 750 mg tablet leaflet; one standard dose is two tablets. |
| treatment_days | integer | – | Planned number of days. Omit only if unknown; then the 14-day limit cannot be assessed. |
No output schema declared.
No examples provided.
get_chunk Get Chunk ~219
Retrieve an indexed chunk. Prefer the exact uid returned by search_content; alternatively provide documentId and chunkIndex. Search first if you have no fragment reference. Use sourceId and domain to restrict the lookup. Context contains adjacent chunks only.
| Name | Type | Req | Description |
|---|---|---|---|
| chunkIndex | integer | – | Chunk position within the document. Zero is valid. |
| contextAfter | integer | – | Number of following chunks to include. Defaults to 0. |
| contextBefore | integer | – | Number of previous chunks to include. Defaults to 0. |
| documentId | string | – | Document identifier. Requires chunkIndex. |
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase. |
| sourceId | string | – | Optional source id used to scope the lookup, for example ciclopoli-de. |
| uid | string | – | Preferred. Exact chunk uid returned by search_content. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
get_official_prospecto Get Official Almax Prospectus ~66
Return the indexed Markdown text of a prospectus PDF published on Almax.com for an explicit presentation, with the original PDF URL. This uses Almirall's indexed content and does not independently check the current AEMPS version.
| Name | Type | Req | Description |
|---|---|---|---|
| presentation_id | string | yes | – |
No output schema declared.
No examples provided.
get_page Get Page ~200
Retrieve an indexed page using its exact url or documentId. If you do not have a page reference, use search_content or list_pages first, then pass the returned url or documentId. Returns chunks ordered by chunkIndex plus a compact heading structure.
| Name | Type | Req | Description |
|---|---|---|---|
| documentId | string | – | Exact document identifier returned by search_content or list_pages. |
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| sourceId | string | – | Optional source id filter, for example physio-relax-de. |
| top | integer | – | Maximum chunks to return. Defaults to 30. |
| url | string | – | Exact page URL returned by search_content or list_pages. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
get_source_map Get Source Map ~165
Build a navigable map of an indexed source or domain with pages, documents, headings, and chunk ranges.
| Name | Type | Req | Description |
|---|---|---|---|
| documentId | string | – | Optional document id filter. |
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum chunks to inspect for the map. Defaults to 30. |
| url | string | – | Optional exact page URL filter. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
list_pages List Pages ~186
List indexed pages available within a sourceId or domain. Each page has a url and may have documentIds; reuse a returned url or an entry from documentIds unchanged with get_page. This lists pages, not chunk uids.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| query | string | – | Optional search query to narrow page discovery. Use * or omit for broad discovery. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum chunks to inspect for page discovery. Defaults to 30. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
list_sources List Sources ~265
Discovery tool for indexed brands, sites, and domains. Use this when you need to discover or disambiguate which indexed domain/sourceId corresponds to a brand or product name, especially if an initial broad search needs narrowing. search_content does not require domain or sourceId, so prefer calling list_sources as an optional discovery step rather than as a mandatory prerequisite. It helps determine whether this MCP has a relevant indexed source and which domain or sourceId to pass into search_content or other tools.
| Name | Type | Req | Description |
|---|---|---|---|
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| query | string | – | Optional query to list sources related to a topic. Use * or omit for broad source discovery. |
| skip | integer | – | Number of matching chunks to skip before collecting the next page of sources. Defaults to 0. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum chunks to inspect for source discovery. Defaults to 30. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
match_almax_prompt Match Almax Prompt ~71
Classify a Spanish prompt or phrase related to Almax into the closest editorial intent from the corpus. Use this when the client needs to detect which predefined Almax topic a user sentence matches before routing to another tool or template.
| Name | Type | Req | Description |
|---|---|---|---|
| text | string | yes | Phrase, prompt, or user text to classify. |
No output schema declared.
No examples provided.
search_content Search Content ~544
Primary tool for answering natural-language questions over indexed website and landing-page content. Use this whenever the user asks what a brand, product, or site says about ingredients, plant extracts, composition, contraindications, usage, benefits, claims, FAQs, or evidence. This includes questions that only mention a brand or product name, for example 'What ingredients or plant extracts does Physio Relax mention?'. Call this tool directly with the question even if domain or sourceId are unknown; those fields are optional narrowing filters, not required inputs. If you need to discover or disambiguate the indexed domain or sourceId for a second narrowed call, use list_sources. Searches content with keyword, semantic, and vector search, and can filter by domain, url, sourceId, or documentId. Results are indexed chunks: reuse a returned uid unchanged with get_chunk, or its documentId and chunkIndex together; reuse a returned url or documentId with get_page for the page. Do not invent missing identifiers. If no search results are found, the tool returns only a no-results text message in the query language when it can be detected. Use that message as the entire user-facing answer while preserving its meaning. The final answer must explicitly say that no sufficient information or indexed mention was found in Almirall's public content for the query, avoid confirming unsupported details, and suggest another question or Almirall's official channels. When this no-results message is returned, stop and do not add counts, bullet lists, related products, examples, search traces, or conclusions from auxiliary tool calls. Do not summarize, explain, or replace it with an unrelated response.
| Name | Type | Req | Description |
|---|---|---|---|
| documentId | string | – | Optional crawler document id to restrict results to one indexed page/document. |
| domain | string | – | Optional domain filter. A leading www. is removed and the domain is normalized to lowercase; for example, www.ciclopoli.de resolves to ciclopoli.de. |
| preferredLanguage | string | – | Optional preferred language tag (for example es, en, or de). The value is echoed in the response as a client hint; indexed result text remains in its source language. |
| query | string | yes | Natural-language question or keywords to search in crawled website content. |
| sourceId | string | – | Optional crawler source id, for example physio-relax-de. |
| top | integer | – | Maximum number of search results to return. Defaults to the server setting. |
| url | string | – | Optional exact crawled page URL filter. |
| userLocation | object | – | Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it. |
No output schema declared.
No examples provided.
search_tools Search Tools ~84
Find available Almirall MCP tools by name, purpose, or input. Supply a non-empty query describing the tool or task, for example {"query":"search indexed content"}. Returns matching tool definitions. Use the MCP tools/list method to discover the complete catalog.
| Name | Type | Req | Description |
|---|---|---|---|
| query | string | yes | Required non-empty words describing the tool or task, for example 'search indexed content'. |
No output schema declared.
No examples provided.
How do I install the Almirall MCP server?
Almirall MCP is a hosted endpoint at https://mcp.almirall.com/mcp, so there is nothing to install locally. Ready-made configuration for Claude, Cursor, VS Code, Codex and 5 more is on this page, copied from each client's own documentation.
remote · mcp.almirall.com
claude mcp add --transport http com-almirall-mcp 'https://mcp.almirall.com/mcp'
What is the Almirall MCP server?
Almirall MCP is listed in the public MCP registry as com.almirall/mcp. Official Almirall company, product and brand info: Almax, Hidroxil, Calmatel, Cicopoli and more. This page covers its hosted endpoint (https://mcp.almirall.com/mcp).
Is the Almirall MCP server safe to use?
Almirall MCP scores 87 out of 100 on VerifyMCP. That is a record of what we were able to check automatically, not an endorsement. The category breakdown on this page shows every signal behind the number, including the ones we could not confirm.
What tools does the Almirall MCP server expose?
Almirall MCP exposes 14 tools: search_tools, search_content, get_chunk, get_page, get_source_map, and 9 more. Their descriptions and schemas cost roughly 2,951 tokens of context every time the server is loaded.
Does the Almirall MCP server require authentication?
No. We connected to Almirall MCP without credentials and it answered, so anything it exposes is reachable by anyone who knows the address.
Is the Almirall MCP server still maintained?
Almirall MCP is still listed as active in the MCP registry. We last reached this channel on 21 November 2026. Those dates come from our own scans of the registry and the channel itself, not from anything the publisher announced.
What did VerifyMCP test on the Almirall MCP server?
VerifyMCP ran 13 checks on Almirall MCP, covering TLS certificate, Authorization, HTTPS, HSTS header and 9 more. Supply Chain Security and Provenance & Transparency do not apply to a hosted endpoint, so they were not tested. The score does not measure everything, and the scoring documentation lists what it leaves out.